These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17673497)

  • 1. Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease--ready for prime time?
    Korantzopoulos P; Elisaf M; Milionis HJ
    Nephrol Dial Transplant; 2007 Oct; 22(10):2768-74. PubMed ID: 17673497
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome now linked to kidney disease. The five components that make up metabolic syndrome are deadly, but you can take steps to prevent or contain them.
    Duke Med Health News; 2011 Nov; 17(11):4-5. PubMed ID: 22211251
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular disease in chronic renal failure. Risk factors and prevention.
    Henriquez D; Dikow R; Ritz E
    Nefrologia; 2004; 24 Suppl 4():34-9. PubMed ID: 15279384
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome: a fata morgana?
    Bakker SJ; Gansevoort RT; de Zeeuw D
    Nephrol Dial Transplant; 2007 Jan; 22(1):15-20. PubMed ID: 17050636
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes: an alternate take from a generalist.
    Manhapra A
    J Am Coll Cardiol; 2004 Mar; 43(5):924; author reply 924-5. PubMed ID: 14998637
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?
    Schelling JR; Sedor JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2773-4. PubMed ID: 15504930
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrahepatic implications of metabolic syndrome.
    Watt KD
    Liver Transpl; 2013 Nov; 19 Suppl 2():S56-61. PubMed ID: 23960041
    [No Abstract]   [Full Text] [Related]  

  • 14. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and cardiovascular disease: part 2.
    Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Hisayama Study].
    Kiyohara Y
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():63-7. PubMed ID: 21766574
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
    Sarafidis PA; Lasaridis AN
    J Cardiometab Syndr; 2008; 3(3):183-7. PubMed ID: 18983337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal manifestations of the metabolic syndrome.
    Tuttle KR
    Nephrol Dial Transplant; 2005 May; 20(5):861-4. PubMed ID: 15769811
    [No Abstract]   [Full Text] [Related]  

  • 20. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.